Table 4.
The logistic regression analyses of apCR after NAT.
| Factors | apCR | non-apCR | Univariable p value | Multivariable p value |
|---|---|---|---|---|
| Tumor stage | 0.485 | |||
| T1 | 6 | 2 | ||
| T2 | 36 | 20 | ||
| T3 | 10 | 9 | ||
| T4 | 10 | 10 | ||
| Nodal stage | 0.005 | OR 0.507; 95% CI: 0.289-0.888 p=0.018 |
||
| N1 | 37 | 11 | ||
| N2 | 13 | 10 | ||
| N3 | 12 | 20 | ||
| Tumor type | 0.022 | OR 0.144; 95% CI: 0.024-0.855 p=0.033 |
||
| IDC 1 | 2 | 1 | ||
| IDC 2 | 60 | 34 | ||
| IDC 3 | 0 | 3 | ||
| others | 0 | 3 | ||
| ER status | 0.066 | |||
| positive | 31 | 13 | ||
| negative | 31 | 28 | ||
| ER change | ||||
| yes | 25 | 27 | 0.103 | |
| no | 3 | 10 | ||
| PR status | ||||
| positive | 38 | 28 | 0.468 | |
| negative | 24 | 13 | ||
| PR change | ||||
| yes | 25 | 34 | 0.719 | |
| no | 3 | 3 | ||
| HER-2 change | ||||
| yes | 27 | 36 | 0.417 | |
| no | 2 | 1 | ||
| POTEH-AS1 level | 0.003 | 0.074 | ||
| <11.225 | 42 | 38 | ||
| ≥11.225 | 20 | 3 | ||
| AC00975.1 level | 0.011 | 0.362 | ||
| <12.57 | 33 | 32 | ||
| ≥12.57 | 29 | 9 | ||
| AL390243.1 level | <0.001 | OR 5.143; 95% CI: 1.570-16.847 p=0.007 |
||
| <13.02 | 24 | 31 | ||
| ≥13.02 | 38 | 10 | ||
| TRBV level | 0.092 | |||
| <12.15 | 20 | 20 | ||
| ≥12.15 | 42 | 21 | ||
| RUVBL1-AS1 | 0.066 | |||
| <13.34 | 31 | 28 | ||
| ≥13.34 | 31 | 13 | ||
| D-dimer | 0.180 | |||
| <0.4 mg/L | 31 | 15 | ||
| ≥0.4 mg/L | 31 | 26 | ||
| Fibrinogen level | 0.547 | |||
| <2.96 g/L | 34 | 20 | ||
| ≥2.96 g/L | 28 | 21 | ||
| NLR | 0.494 | |||
| <4.413 | 29 | 22 | ||
| ≥4.413 | 33 | 19 |